Biotech Distilled
Substack ↗
Subscribe
Subscribe
Substack ↗
About
Research
Areas
Modalities
Phases
Targets
Track record
Movers
The Lead Compound
Home
›
Targets
› IL-23p19
IL-23p19
(1 companies · 2 programs)
Companies with an active program directed at IL-23p19.
Oruka Therapeutics, Inc.
ORKA
ORKA-001
— Psoriasis
Phase 1
ORKA-021
— Psoriasis